The effect of atorvastatin in the treatment of ulcerative colitis
Phase 2
- Conditions
- lcerative Colitis.Ulcerative colitis
- Registration Number
- IRCT2016102730528N1
- Lead Sponsor
- Vice chancellor for research, Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Main inclusion criteria: developing ulcerative colitis with pathologic confirmation; patients at the age of 18-60 years old.
Main exclusion criteria: not taking medication as directed by doctor; drug allergy or severe drug side effects; cancer; history of surgery on the gastrointestinal tract; malabsorption disease; vasculitis disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of remission. Timepoint: Every 3 months since study start. Method of measurement: Day.;Frequency of flare. Timepoint: Every 3 months since study start. Method of measurement: Number.;The need for steroids. Timepoint: Every 3 months since study start. Method of measurement: Miligram per kilogram.;Number of hospitalization. Timepoint: Every 3 months since study start. Method of measurement: Number.
- Secondary Outcome Measures
Name Time Method